# AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation

> **NCT01435291** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 45 (actual)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** Advagraf Capsule
- **DRUG:** Prograf Capsule

## Key facts

- **NCT ID:** NCT01435291
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-05
- **Final completion:** 2013-07
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01435291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01435291, "AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01435291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*